Search Results for 'controversial multiple sclerosis'
1 results found.
Tysabri can improve life quality, says Elan
Athlone-based Elan has claimed that a post-hoc analysis showed that its controversial multiple sclerosis drug Tysabri increases the probability of achieving sustained improvement in physical disability over two years when compared to a placebo.
